China Yct International Group, Inc. (CYIG) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket
 


China Yct International Group, Inc.  (CYIG)


China Yct International Group,'s ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is China Yct International Group,'s ROI in the third quarter of 2019?
China Yct International Group, Inc. achieved a return on average invested assets (ROI) of 14.27 % in its third quarter of 2019, this is above CYIG's average return on investment of 14.11%.
China Yct International Group, Inc. invested over the 12 months ending in its third quarter of 2019 $112 million

ROI has improved compared to 13.15% in the second quarter of 2019, due to net income growth.

Within the Healthcare sector 84 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2018 quarter, so far to 712, from total ROI ranking in the second quarter of 2019 at 834.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2018)
III. Quarter
(Sep 30 2018)
II. Quarter
(Jun 30 2018)
I. Quarter
(Mar 31 2018)
IV. Quarter
(Dec 31 2017)
III. Quarter
Y / Y Investment Change TTM 14.85 % 19.23 % 22.5 % 23.76 % 20.68 %
Y / Y Net Income Change TTM 22.79 % 12.75 % 19.46 % 81.05 % 401.93 %
Investment (TTM) in Millions 115 110 110 111 104
Return On Investment (TTM) 14.27 % 13.15 % 11.69 % 11.43 % 13.35 %
CYIG's Overall Ranking # 712 # 834 # 801 # 975 # 835
Seq. Investment Change TTM 2.5 % 2.48 % 3.61 % 5.52 % 6.41 %
Seq. Net Income Change TTM 11.25 % 15.28 % 5.95 % -9.64 % 2.16 %
Net Income (TTM) in Millions 16 14 12 12 13




Return On Investment CYIG's Ranking
Within: No.
Industry # 43
Sector # 85
Overall # 712

Return On Investment Statistics
High Average Low
90.58 %
14.11 %
-44.02 %
(Mar 31 2013)   (Jun 30 2012)







Financial Statements
China Yct International Group,'s III. Quarter Investments $ 115 Millions CYIG's Balance sheet
China Yct International Group,'s III. Quarter Income $ 4 Millions Quarterly CYIG's Income Statement
CYIG's Income by Division See CYIG's Income by Division


CYIG Annual Return On Investment (Mar 31 2018)
2018
(Mar 31 2017)
2017
(Mar 31 2016)
2016
(Mar 31 2015)
2015
(Mar 31 2014)
2014
Total Investments in Millions 111 90 80 75 66
Y / Y Investment Growth 23.94 % 11.62 % 6.6 % 13.61 % 15.61 %
Net Income in Millions 12 10 8 9 8
Y / Y Net Income Growth 16.75 % 19.46 % -5.33 % 9.48 % -0 %
Annual Return On Investment 10.56 % 11.21 % 10.47 % 11.79 % 12.24 %


Annual Roi Comment
In the fiscal year 2018 ROI deteriorated to 10.56 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CYIG's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CYIG's Competitors
Subscribers only: Roi for China Yct International Group,'s Suppliers
Subscribers only: Return On Investment for CYIG's Customers

Other Ratios
CYIG's Roa CYIG's Inventory Turnover Ratio CYIG's Growth Rates CYIG's Dividend Statistics
CYIG's Profitability Ratios CYIG's Asset Turnover Ratio CYIG's Dividend Growth
CYIG's Roe CYIG's Valuation Ratios CYIG's Financial Strength Ratios CYIG's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2018, within Healthcare Sector ROI
Cv Sciences Inc   37.84 %
Oramed Pharmaceuticals Inc  36.59 %
Molecular Templates Inc   33.73 %
Align Technology inc   32.83 %
Fuse Medical Inc   31.41 %
Idexx Laboratories Inc  31.07 %
Corcept Therapeutics Inc  30.33 %
Proteo Inc  30.29 %
Abiomed Inc   28.57 %
Tivity Health Inc   27.48 %
Mettler toledo International Inc   27.38 %
Chemed Corporation  26.69 %
Regeneron Pharmaceuticals Inc   26.34 %
Alpha Pro Tech Ltd   25.27 %
Regenxbio Inc   24.30 %
Lifevantage Corp  23.53 %
Enanta Pharmaceuticals Inc  23.02 %
Biospecifics Technologies Corp  23.01 %
Amedisys Inc  22.08 %
Strongbridge Biopharma plc  21.43 %
Psychemedics Corporation  21.29 %
Masimo Corp  21.18 %
Bristol myers Squibb Company  20.68 %
Biogen Inc   20.33 %
United Therapeutics Corporation  20.23 %
Utah Medical Products Inc  19.91 %
Kamada Ltd   19.46 %
Varian Medical Systems Inc   19.44 %
Stryker Corp  18.80 %
Icon Plc  18.40 %


Date modified: 2026-09-08T15:09:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.